These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 9567608)

  • 1. [Anesthesiologic management of susceptible children at risk for malignant hyperthermia].
    Ferrari F; D'Alessandro S; Pietrandrea G; Villani A
    Minerva Anestesiol; 1997 Oct; 63(10):311-4. PubMed ID: 9567608
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Muscle biopsy for malignant hyperthermia screening in children.
    Ummenhofer W; Roesslein R; Sutter PM; Moser N; Kern C; Urwyler A
    Eur J Pediatr Surg; 1997 Oct; 7(5):259-62. PubMed ID: 9402480
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Malignant hyperthermia in Austria. III. Anesthesia in susceptible patients].
    Mauritz W; Hackl W; Sporn P; Steinbereithner K
    Anaesthesist; 1988 Aug; 37(8):522-8. PubMed ID: 3177878
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Screening for malignant hyperthermia susceptibility.
    Anderson IL; Rawstron RE; Dunlop DJ
    N Z Med J; 1980 Jun; 91(661):417-9. PubMed ID: 6930029
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Diagnosis of malignant hyperthermia susceptibility. 2. Anesthesia for muscle biopsy. Differential diagnosis in negative test results].
    Breucking E; Mortier W
    Anaesthesist; 1993 Oct; 42(10):684-90. PubMed ID: 8250202
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Masseter muscle rigidity and malignant hyperthermia susceptibility.
    Rosenberg H; Fletcher JE
    Anesth Analg; 1986 Feb; 65(2):161-4. PubMed ID: 3942303
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anesthesia in malignant hyperthermia susceptible patients.
    Mauritz W; Hackl W; Winkler M; Sporn P; Steinbereithner K
    Acta Anaesthesiol Belg; 1990; 41(2):87-94. PubMed ID: 1973553
    [TBL] [Abstract][Full Text] [Related]  

  • 8. McArdle's disease and anaesthesia: case reports. Review of potential problems and association with malignant hyperthermia.
    Bollig G; Mohr S; Raeder J
    Acta Anaesthesiol Scand; 2005 Sep; 49(8):1077-83. PubMed ID: 16095447
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anesthesia for patients with a history of malignant hyperthermia.
    Wappler F
    Curr Opin Anaesthesiol; 2010 Jun; 23(3):417-22. PubMed ID: 20173632
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anaesthesia in malignant hyperthermia-susceptible patients without dantrolene prophylaxis: a report of 30 cases.
    Hackl W; Mauritz W; Winkler M; Sporn P; Steinbereithner K
    Acta Anaesthesiol Scand; 1990 Oct; 34(7):534-7. PubMed ID: 2244439
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Malignant hyperthermia in the oral and maxillofacial surgery patient: an update.
    Patil PM
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2011 Sep; 112(3):e1-7. PubMed ID: 21827956
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Israeli Diagnostic Center for Malignant Hyperthermia: 7-years' accumulated experience.
    Glauber V; Ben Abraham R; Zweig A; Perel A
    Isr J Med Sci; 1997 Oct; 33(10):643-7. PubMed ID: 9397136
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety of general anesthesia in patients previously tested negative for malignant hyperthermia susceptibility.
    Allen GC; Rosenberg H; Fletcher JE
    Anesthesiology; 1990 Apr; 72(4):619-22. PubMed ID: 2321777
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ryanodine contracture threshold times for diagnosis of malignant hyperthermia susceptibility: an experimental approach from a single laboratory.
    Weisshorn R; Wappler F; Fiege M; Gerbershagen MU; Kolodzie K; Alberts P; Horn EP; Schulte Am Esch J
    J Clin Anesth; 2004 Aug; 16(5):353-7. PubMed ID: 15374556
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Anesthetic management of the King-Denborough syndrome].
    Iwatsubo T; Yoshikawa M; Karashima Y; Kurita N; Shimoda T; Takahashi H; Horiuchi T; Kitaguchi K; Furuya H
    Masui; 2001 Apr; 50(4):390-3. PubMed ID: 11345752
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Malignant hyperthermia: current perspectives.
    Felice-Johnson J; Sudds T; Bennett G
    Am J Hosp Pharm; 1981 May; 38(5):646-51. PubMed ID: 7282692
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Fulminant MH crisis during the ninth general anaesthesia].
    Adam H; Gottschaldt U; Pausch NC; Rüffert H; Sipli KM
    Anasthesiol Intensivmed Notfallmed Schmerzther; 2007 Oct; 42(10):692-9. PubMed ID: 17968765
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hyperthermia in the pediatric intensive care unit--is it malignant hyperthermia?
    Schleelein LE; Litman RS
    Paediatr Anaesth; 2009 Nov; 19(11):1113-8. PubMed ID: 19694974
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Transient normalisation of CK blood levels in patients susceptible to malignant hyperthermia by oral administration of dantrolene (author's transl)].
    Bernhardt D
    Anaesthesist; 1982 May; 31(5):252-4. PubMed ID: 7103034
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of otolaryngic patients susceptible to malignant hyperthermia without dantrolene.
    Derkay CS; Grundfast KM
    Otolaryngol Head Neck Surg; 1991 Nov; 105(5):680-6. PubMed ID: 1754251
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.